Susquehanna International Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
587,977
+395,556
| +206% | +$6.73M | ﹤0.01% | 731 |
|
|
2025
Q1 | $3.76M | Buy |
192,421
+61,985
| +48% | +$1.21M | ﹤0.01% | 1514 |
|
|
2024
Q4 | $3.23M | Buy |
130,436
+44,789
| +52% | +$1.11M | ﹤0.01% | 1444 |
|
|
2024
Q3 | $2.1M | Sell |
85,647
-80,116
| -48% | -$1.96M | ﹤0.01% | 1815 |
|
|
2024
Q2 | $3.88M | Buy |
165,763
+84,134
| +103% | +$1.97M | ﹤0.01% | 1182 |
|
|
2024
Q1 | $2.7M | Sell |
81,629
-99,110
| -55% | -$3.27M | ﹤0.01% | 1506 |
|
|
2023
Q4 | $4.92M | Sell |
180,739
-191
| -0.1% | -$5.2K | ﹤0.01% | 1155 |
|
|
2023
Q3 | $4.35M | Buy |
180,930
+156,825
| +651% | +$3.77M | ﹤0.01% | 1205 |
|
|
2023
Q2 | $770K | Sell |
24,105
-157,252
| -87% | -$5.02M | ﹤0.01% | 3060 |
|
|
2023
Q1 | $5.55M | Buy |
181,357
+127,212
| +235% | +$3.9M | ﹤0.01% | 1050 |
|
|
2022
Q4 | $2.12M | Sell |
54,145
-14,945
| -22% | -$584K | ﹤0.01% | 1544 |
|
|
2022
Q3 | $3.29M | Buy |
69,090
+5,288
| +8% | +$252K | ﹤0.01% | 1171 |
|
|
2022
Q2 | $2.47M | Sell |
63,802
-8,866
| -12% | -$343K | ﹤0.01% | 1461 |
|
|
2022
Q1 | $4.16M | Sell |
72,668
-22,588
| -24% | -$1.29M | ﹤0.01% | 1312 |
|
|
2021
Q4 | $7.59M | Buy |
95,256
+31,770
| +50% | +$2.53M | ﹤0.01% | 923 |
|
|
2021
Q3 | $5.52M | Buy |
63,486
+44,868
| +241% | +$3.9M | ﹤0.01% | 1099 |
|
|
2021
Q2 | $2.4M | Sell |
18,618
-8,039
| -30% | -$1.03M | ﹤0.01% | 1881 |
|
|
2021
Q1 | $2.13M | Sell |
26,657
-41,547
| -61% | -$3.33M | ﹤0.01% | 2048 |
|
|
2020
Q4 | $5.57M | Buy |
+68,204
| New | +$5.57M | ﹤0.01% | 931 |
|